亨廷顿病的溶酶体质量控制的损害
Paola Rusmini1, Francesco Mina1, Marta Valenza2
1Dipartimento di Scienze Farmacologiche e Biomolecolari "Rodolfo Paoletti", Dipartimento di Eccellenza 2018-2027, Università degli Studi di Milano, Milan, Italy.
Cell death & disease
|October 28, 2025
概括
亨廷顿病 (HD) 涉及突变的亨廷丁 (muHTT) 聚合物绑定TFEB/TFE3,损害 lysosome质量控制和损害神经元. 恢复TFEB/TFE3功能可能会减少muHTT聚合并改善溶酶体健康.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 亨廷顿病 (HD) 是一种神经退行性疾病,由亨廷丁蛋白 (muHTT) 中的多重胺 (polyQ) 扩张引起,导致蛋白质错误折叠和聚合.
- 这些muHTT聚合物通过隔离必要的蛋白质来破坏细胞平衡,包括调节 lysosome 功能的转录因子,如TFEB和TFE3.
- 溶解体对于细胞废物处理和信号传递至关重要;它们的功能障碍,特别是溶解体膜通透性 (LMP),有助于神经退行.
研究的目的:
- 调查转录因子TFEB和TFE3在亨廷顿病病原发生中的作用.
- 阐明muHTT聚合,溶酶体功能障碍和HD中的溶酶体质量控制 (LQC) 系统之间的关系.
- 探索HD模型中调节TFEB和TFE3活性的治疗潜力.
主要方法:
- 利用亨廷顿病小鼠和表达突变亨廷丁 (muHTT) 的细胞模型与多重氨酸扩展.
- 研究了TFEB和TFE3与muHTT聚合物和溶酶体膜通透性 (LMP) 相关的亚细胞局部化.
- 评估了TFEB和TFE3操纵 (沉默和过度表达) 对muHTT聚合,LGALS3水平和溶酶体动态 (溶酶体,溶酶体替代) 的影响.
主要成果:
- 在HD模型中,TFEB和TFE3被发现被隔离在muHTT聚合物中.
- muHTT聚合与LMP和加勒-3 (LGALS3) 转移到溶酶体有关,严重程度与polyQ长度相关.
- TFEB/TFE3 knockdown 加剧了 muHTT 聚合,而过度表达通过促进溶解体和溶解体替代减少了包含和 LGALS3 积累.
结论:
- 在muHTT聚合物中对TFEB和TFE3的隔离会损害溶酶体质量控制 (LQC) 系统,增加神经元对HD溶酶体损伤的脆弱性.
- 降低TFEB/TFE3的生物可用性阻止了对溶解体损伤的适当反应,导致功能障碍的溶解体的积累.
- 调节TFEB和TFE3为亨廷顿病提供了潜在的治疗策略,通过减轻muHTT聚合和恢复 lysosomal homeostasis.
更多相关视频
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
3.0K
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
6.6K
相关概念视频
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
